All drugs and medical devices must be accompanied by extensive and complex product information. This is highly regulated because any mistake or error could threaten patient safety and outcomes. Back in 2001, we were approached by a key player in life sciences to help them overcome these considerable labeling and regulated content management challenges. Together we ensured product data, expiry dates, dosage advice, warning symbols, and every other piece of regulated content required on both the labels and IFUs/leaflets that accompany their products, were correct when printed. These small details are critically important and matter to every patient and healthcare professional that relies on a drug or medical device. That is why this has been our sole focus for over 15 years, ensuring patient safety and avoiding costly recalls for our clients. Today, our unique products and technologies are being used to assure that these essential details appear correctly on the 10 million+ medical devices and pharmaceutical products that our customers research and manufacture annually. 𝗣𝗥𝗜𝗦𝗬𝗠 𝟯𝟲𝟬 is designed to specifically address the unique complexities of medical device and life sciences regulated labeling and content management, ensuring compliance with global regulations. It enables the necessary visibility and control over all aspects of label and artwork design, and content and production output, that are essential within these highly regulated industries. Complete control and automation of the processes required to create, manage and change approved product content substantially reduces risk. This is combined with the ability to verify and assure the use of the correct approved content, to provide complete certainty to our clients. Deployable as an industry-specific validated cloud offering, PRISYM 360 minimizes implementation effort, shortens our clients’ ‘time to value’ and provides access to an upgrade path to take advantage of industry leading knowledge.